Expertise in
2
conditions

Ji W. Roh

Yongin, KR 
Expertise in
2
conditions
Yongin, KR 

Overview

Ji Roh practices practicing medicine in Yongin, Republic of Korea.

Roh is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Coronary Heart Disease, Heart Attack, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Angioplasty.

They are actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 2 clinical trials.

Locations

Yongin, Republic of Korea
Other Locations
Gyeonggi-do, Republic of Korea
Bucheon St. Mary's Hospital, Puch'on, Republic of Korea
Bucheon St. Mary's Hospital, Seoul, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

In vivO Study of assessmeNt for Efficacy and safetY of Zotarolimus-eluting Stent OVERexpansion With Optical Coherence Tomography (ONYSOVER Trial)
In vivO Study of assessmeNt for Efficacy and safetY of Zotarolimus-eluting Stent OVERexpansion With Optical Coherence Tomography (ONYSOVER Trial)
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Device
Feasibility of Percutaneous Coronary Intervention Using a 7-Fr Thin Walled Sheath Via the Distal Radial Approach: a Prospective Observational Study (SEVEN-BOX)
Feasibility of Percutaneous Coronary Intervention Using a 7-Fr Thin Walled Sheath Via the Distal Radial Approach: a Prospective Observational Study (SEVEN-BOX)
Enrollment Status: Completed
Publish Date: November 25, 2025
Intervention Type: Procedure
View 1 Less Clinical Trial

46 Total Publications

Cardiovascular outcomes with thiazolidinediones and sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus undergoing peripheral artery revascularization.
Cardiovascular outcomes with thiazolidinediones and sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus undergoing peripheral artery revascularization.
Journal: Diabetes research and clinical practice
Published: January 01, 2026

Frequently Asked Questions about Ji W. Roh

Is Ji W. Roh a top-rated expert for Percutaneous Coronary Intervention (PCI)?

MediFind is an objective health platform that identifies experts based on real-world data. Ji W. Roh is classified as an Advanced expert for Percutaneous Coronary Intervention (PCI), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ji W. Roh participate in research or clinical trials?

Yes. Ji W. Roh has published 46 articles and abstracts on conditions like Percutaneous Coronary Intervention (PCI). You can view a list of Ji W. Roh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Roh's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile